This finding is consistent with a previous genome-wide transcriptome analysis of peripheral blood mononuclear cells (PBMC's) from 22q11DS SZ patients [69], in which ERK/MAPK signaling was also identified as one of the top canonical pathways disrupted in patients. This evidence concerns the gene MAPK1 and 22q11.2 deletion syndrome.